Explorar vídeo

En este video, la Dra. Sara Arias Villate, médico especialista de farmacología clínica, aborda el uso de biosimilares su decodificación desde la perspectiva de las autoridades regulatorias.

En este video, la Dra. Rosa Helena Bustos, la cual hace parte del departamento de Farmacología en la Universidad de la Sabana, nos invita a reflexionar de manera crítica sobre la importancia del uso de Biosimilares y como esto es una práctica segur.

Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.

CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.

View comprehensive coverage of Breast Cancer from ESMO 2022

Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.

En este video, el Dr. Julio García, médico QF de la Universidad de la Sabana, nos invita a reflexionar de manera crítica sobre la importancia del uso de Biosimilares y el acceso de estos en el sistema de salud.

Summary of Key Abstracts from SABCS 2022

Endocrine therapy is the mainstay in the management of patients with Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Tumor progression in ER+ve MBC could be attributed to genomic alterations such as ESR mutations.

Dr Scott Soefje, PharmD, Mayo Clinic
Provides a perspective “Quality Management Systems in Pharmacy Practice”.